OncoCyte Corp CEO Ronald Andrews receives $2.1M in 2019

OncoCyte Corp reports 2019 executive compensation

By ExecPay News

Published: May 26, 2020

OncoCyte Corp reported fiscal year 2019 executive compensation information on May 26, 2020.
In 2019, four executives at OncoCyte Corp received on average a compensation package of $1.5M, a 72% increase compared to previous year.
Average pay of disclosed executives at OncoCyte Corp
Ronald Andrews, Chief Executive Officer, received $2.1M in total. 78.73% of Andrews' compensation, or $1.6M, was in option awards. Andrews also received $276.3K in salary and $163.2K in stock awards.
William Annett, Chief Executive Officer, received a compensation package of $1.6M, which increased by 76% compared to previous year. 58.66% of the compensation package, or $955.5K, was in option awards.
Lyndal K. Hesterberg, Chief Scientific Officer, earned $1.2M in 2019, a 43% increase compared to previous year.
Mitchell Levine, Chief Financial Officer, received $1.2M in 2019, which increases by 33% compared to 2018.

Related executives

Ronald Andrews

OncoCyte Corp

Chief Executive Officer

Lyndal Hesterberg

OncoCyte Corp

Chief Scientific Officer

Mitchell Levine

OncoCyte Corp

Chief Financial Officer

William Annett

OncoCyte Corp

Chief Executive Officer

You may also like

Source: SEC filing on May 26, 2020.